Concord Biotech Limited
Concord Biotech Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: CONCORDBIO and BSE: 543960 (ISIN INE338H01029).
It has a market capitalisation of ₹13,452 crore, a last close of ₹1,286 on 2026-10-19, a one-year return of -16.0%.
Valuation: a price-to-earnings ratio of 48.85x, a price-to-book ratio of 6.67x, a dividend yield of 0.6%.
Profitability: return on equity of 13.6%, return on capital employed of 17.5%, an operating margin of 35.0%.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 44.1%.
| Metric | Value |
|---|---|
| Market capitalisation | 13,452 |
| Last close | ₹1,286 |
| P/E (TTM) | 48.85x |
| P/B | 6.67x |
| Dividend yield | 0.6% |
| ROE (FY) | 13.6% |
| ROCE (FY) | 17.5% |
| Operating margin (TTM) | 35.0% |
| Debt / equity | 0.00x |
| Promoter holding | 44.1% |
| 1-year return | -16.0% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means